Literature DB >> 17969276

[Detection of hepatitis B and hepatitis C markers in HIV positive patients, 2000-2004].

Marité Bello Corredor1, Licel de los Angeles Rodríguez Lay, Aidonis Gutiérrez Moreno, Susel Sariego Frómeta, Ma Caridad Montalvo Villalba, Adriana Sánchez Sol.   

Abstract

A marked association exists among the hepatitis B virus (HBV), the hepatitis C virus (HCV) and the type 1 human immunodeficiency virus (HIV), since the transmission route and the risk groups are very similar. The objective of this paper was to know the coinfection among HBV, HCV and HIV in the studied period. 2 994 serum samples from HIV (+) patients were received at the National Reference Laboratory of Viral Hepatitis (IPK) during 2000-2004 to investigate hepatitis B surface antigen (HRsAg) and anti HCV antibodies, both by the UMELISA technique (Immunoassay Center, CIE, Cuba). Epi Info program (Version 6.04) was used for statistical analysis. Positivity to HbsAg was found in 10.3%. 10.4% had anti-HCV antibodies, and there was HBV, HCV and HIV coinfection in 1.7% of the patients. We confirmed what is stated in literature on HBV, HCV and HIV coinfections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 17969276

Source DB:  PubMed          Journal:  Rev Cubana Med Trop        ISSN: 0375-0760


  2 in total

Review 1.  Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review.

Authors:  Fatima Mitiko Tengan; Karim Yakub Ibrahim; Bianca Peixoto Dantas; Caroline Manchiero; Mariana Cavalheiro Magri; Wanderley Marques Bernardo
Journal:  BMC Infect Dis       Date:  2016-11-09       Impact factor: 3.090

2.  Prevalence of hepatitis B in people living with HIV/AIDS in Latin America and the Caribbean: a systematic review and meta-analysis.

Authors:  Fatima Mitiko Tengan; Edson Abdala; Marisa Nascimento; Wanderley Marques Bernardo; Antonio Alci Barone
Journal:  BMC Infect Dis       Date:  2017-08-24       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.